Alvogen
Description
A leading specialty generic pharmaceutical company with manufacturing facilities in the United States, Europe and Asia
Sector
Specialty Pharmaceuticals
Website
Status
Exited
Year Invested
2007
GMS Ownership
2007
Under US$ 30M of revenues
GMS Holdings acquired Norwich Pharmaceuticals, a CMO in upstate New York
Founded Alvogen and launched a US generics platform
Founded Alvogen and launched a US generics platform
2009
Partnered with new management team led by Robert Wessman, former CEO of Actavis
Launched global strategy
Launched global strategy
2010 - 2013
Acquisitions in Eastern Europe and Asia
2014
Over US$ 400 million in revenues
Sold stake to Pamplona Capital Management, generating significant returns